Loading organizations...
SINTEF Ventures is the corporate venture capital arm of the SINTEF Group, an independent research organization. It commercializes proprietary R&D via seed and early-stage funds, investing in spin-off companies. These ventures translate SINTEF’s technological advancements into market-ready solutions across energy and healthcare sectors.
Established 2004, SINTEF Ventures originated from the SINTEF Group, founded 1950 in Trondheim, Norway. Its inception reflected a strategic insight: transforming parent organization's intellectual property into viable commercial enterprises. Operating under SINTEF TTO, this arm systematically leverages deep scientific heritage to foster new company creation.
SINTEF Ventures supports start-ups developing products and services from SINTEF’s research. Its vision connects scientific discovery with industrial application, ensuring research yields economic and societal benefits. The organization cultivates an ecosystem for spin-offs to thrive, bringing transformative technologies to market.
SINTEF Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $26.0M Series B in Hystar in January 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 11, 2023 | Hystar | $26.0M Series B | Charlie Clark, Toshihiro Hayashi | Hans Maenhout, Firda, Hillhouse Capital Group, Nippon Steel Trading, Trustbridge Partners |
| Aug 12, 2021 | Nomono | $5.4M Seed Extension | Sintef Ventures, Spintop Ventures | Tvenge OG Adolfsen |
